JUPITER, Fla. (AP) — Florida scientists are studying the genetic makeup of centenarians to develop new drugs that could delay or possibly even reverse age-related diseases.
Scientists from the Florida campus of The Scripps Research Institute and Albert Einstein College of Medicine will share a $9 million grant from the National Institute on Aging.
According to a statement from Scripps, a five-year study will focus on individual genetic differences that could contribute to new therapeutic approaches targeting the aging process itself.
Scripps researcher Paul Robbins says researchers will study “natural longevity mutants” — people who live to age 100 or older without suffering from diseases that trouble other people starting in middle age.
Most Read Nation & World Stories
- Fuller picture emerges of viral video encounter between Native American and Catholic students
- Trump wants to deliver State of Union next week as planned VIEW
- Trump says he directed Sarah Sanders 'not to bother' with White House news briefings
- 9 brains, 3 hearts: Some wild facts about octopuses
- The man who stood behind Trump VIEW
The number of U.S. residents over 65 is expected to double over the next 20 years, adding urgency to the search for new healthy aging strategies.